Africa World 

European drugs regulators approve world’s first Ebola vaccine

The world’s first Ebola vaccine was approved by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a “triumph for public health” that would save many lives. The vaccine, developed by U.S. drugmaker Merck & Co, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in Democratic Republic of Congo. It is also being reviewed under a fast-track system by regulators in the United States. “This vaccine has already saved many lives…

Read More
Africa Central Africa Featured World 

DR Congo: New Ebola vaccine to be used in November

A new and second model of an Ebola vaccine is to be introduced in the Democratic Republic of Congo in November this year. Health officials in the country say this is to help combat the spread of the deadly virus in the country’s eastern provinces. The Johnson & Johnson manufactured vaccine will now be introduced to compliment that of Merck. The Merck manufactured vaccine was introduced this year and administered to thousands of people. A government statement said a first batch of 500,000 doses of the J&J vaccine should arrive…

Read More
Africa Central Africa Featured World 

Burundi begins Ebola vaccination for health officials

Burundi has started vaccinating its health workers against Ebola as it makes efforts to prevent the spread of the disease into its territory. The World Health Organisation (WHO) said on Wednesday that the vaccination is happening near Burundi’s border with the Democratic Republic of Congo. Burundi has not reported of any Ebola cases but does not want to taken by surprise. The Health ministry in Burundi launched vaccination exercise at the Gatumba border crossing point on Tuesday. The Merck’s rVSV-ZEBOV vaccine is being used for this exercise. In a statement…

Read More
Africa East Africa World 

Ebola vaccine trial begins in Uganda as virus spreads

A trial of an experimental Ebola vaccine has started in Uganda as efforts continue to prevent spread of the virus. Health officials in Uganda said the trial started on Monday to deal with a disease that has killed more than 1,800 people in neighbouring Democratic Republic of Congo. The MVA-BN vaccine was developed by Johnson&Johnson and will last for two years, Uganda’s Medical Research Council (MRC) said. The MRC statement revealed that the vaccine will be administered to up to 800 health professionals and frontline workers. These workers will include…

Read More